septum_entry

TL2 Member · Split, HR

Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.

Joined 9 December 2024 · last posted 2d

78 posts, newest first. Showing up to 150.

Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #119 · Evidence › Journal club · 26 Jul 2026 · 2 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #90 · Practice › Interactions · 26 Jul 2026 · 29 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
What a certificate commits its issuer to Replied, post #64 · Analytics › COA interpretation · 20 Jul 2026 · 27 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #77 · Nutrition & Training › Protein & intake · 18 Jul 2026 · 10 likes Adding a null result on Protein density versus volume. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #53 · Pharmacology › Pharmacokinetics · 17 Jul 2026 · 8 likes I would call the community position on Peak-to-trough ratio likely rather than established, and I would be comfortable defending that hedge.
Sleep apnoea improving and the equipment implications Replied, post #15 · Wellbeing › Sleep · 15 Jul 2026 · 7 likes Where sleep worsened at the same time as an escalation and improved afterwards, that sequence is worth recording rather than reasoning about. The general answer and the…
What a reversed-phase purity number actually is Replied, post #56 · Analytics › HPLC & UHPLC · 15 Jul 2026 · 0 likes A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is to change the gradient slope, not to argue about…
Pooling trials with different estimands Replied, post #78 · Evidence › Meta-analyses · 7 Jul 2026 · 20 likes Two people in this thread mean different things by pooling trials with different estimands and are disagreeing about the definition while believing they are disagreeing…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #70 · Sourcing › Red flags · 26 Jun 2026 · 14 likes My position on supplier is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #113 · Sourcing › Logistics · 25 Jun 2026 · 14 likes Coming back to post #109, because the follow-up matters more than the original answer. Genuine question rather than a rhetorical one: has anyone here actually observed…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #50 · Practice › Dosing & titration · 16 Jun 2026 · 5 likes Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.…
Publication patterns in the BPC-157 literature, examined Replied, post #13 · Compounds › Repair & healing peptides · 13 Jun 2026 · 16 likes No notes. Posting so the count is not one.
A structured critique template this community uses — a second dataset Replied, post #7 · Evidence › Study critique · 10 Jun 2026 · 5 likes Answering the structured critique template question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #42 · Analytics › Home & field testing · 8 Jun 2026 · 15 likes The right question for any home test is: what physical quantity does it measure, and what would have to be true for that quantity to answer your question? Most…
An 18-month record including the parts that went badly Replied, post #32 · Outcomes › Progress reports · 4 Jun 2026 · 29 likes Post #28 describes the usual case. This is about the unusual one. One caution on 18-month record: everything above assumes the underlying documentation is what it…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #31 · Practice › Dosing & titration · 19 May 2026 · 4 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Vomiting: when it is expected and when it is a reason to stop — one year on Replied, post #9 · Practice › Side effects · 17 May 2026 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
A plateau that disappeared when I changed how I measured — the long version Replied, post #37 · Outcomes › Progress reports · 12 May 2026 · 0 likes Taking post #34 at face value and following it one step further. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #35 · Devices › Syringes & needles · 8 May 2026 · 5 likes Confirming post #34 from a second method, which matters more than confirming it from a second person. Sharps containers are a legal requirement for disposal in several…
Batch numbers that do not match the vial label Replied, post #13 · Sourcing › Red flags · 6 May 2026 · 0 likes Adding a reference point for batch numbers. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #60 · Practice › Administration · 3 May 2026 · 0 likes Coming back to post #58, because the follow-up matters more than the original answer. Pinch or no pinch: the decision depends on needle length and on your own anatomy.…
Gastro-oesophageal reflux: improving or worsening? Replied, post #37 · Clinical › Comorbidities · 19 Apr 2026 · 0 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public. That has been true for the cases I have seen and…
Spike-and-recover accuracy for a peptide assay Replied, post #76 · Analytics › Method validation · 9 Apr 2026 · 13 likes Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one. I have deliberately not…
[2026 update] Composite endpoints and the component doing the work Replied, post #38 · Evidence › Trials · 21 Mar 2026 · 18 likes The arithmetic in post #37 is right; the assumption feeding it is the part to check. Surrogate endpoints: an endpoint that is not the outcome that matters but is…
The most common factual error about semaglutide on the internet — what changed since Replied, post #46 · Compounds › Semaglutide · 11 Mar 2026 · 3 likes I came in to disagree and I am leaving without a disagreement.
The lowest dose that does anything: is that a real question? Replied, post #25 · Practice › Dosing & titration · 2 Mar 2026 · 27 likes This follows post #24 rather than contradicting it. What I would tell a new member reading about lowest dose for the first time: the confident posts are not the…
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #3 · Compounds › Semaglutide · 23 Feb 2026 · 11 likes Cardiovascular data in people without diabetes is the specific contribution of SELECT, and it is worth being precise that the enrolled population had established…
Mass error in ppm: the arithmetic and the caveat Replied, post #100 · Analytics › Mass spectrometry · 15 Feb 2026 · 22 likes I had written a reply contradicting post #96 and deleted it. Here is what survived. Mass error in parts per million is (observed minus theoretical) divided by…
Coming back to: Training through a dose escalation week Replied, post #12 · Nutrition & Training › Resistance training · 20 Jan 2026 · 0 likes Where the Training through a dose escalation reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #23 · Compounds › Semaglutide · 12 Jan 2026 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Second pass at: Asking a follow-up: new topic or new reply? Replied, post #5 · Start Here › How to Ask · 9 Dec 2025 · 1 like Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Adolescents: a distinct evidence base — one year on Replied, post #41 · Clinical › Special populations · 7 Dec 2025 · 5 likes Bookmarking this. I will come back when I have something worth adding.
Journal club: how we handle discontinuation in obesity trials — what changed since Replied, post #19 · Evidence › Journal club · 3 Dec 2025 · 0 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. Flagging that…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #22 · Practice › Side effects · 10 Nov 2025 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #2 · Compounds › Oral incretins · 8 Nov 2025 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #26 · Compounds › Oral incretins · 1 Nov 2025 · 6 likes Appreciated. The plain phrasing does more work here than a longer post would.
Sleep tracking data and its considerable limitations Replied, post #52 · Wellbeing › Sleep · 21 Oct 2025 · 5 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
Availability by country, dated, with primary sources Replied, post #26 · Access › International · 19 Oct 2025 · 28 likes Same experience here, different supplier, so it is at least not unique to one of them.
Reading SURMOUNT-1 without the press release Replied, post #38 · Compounds › Tirzepatide · 19 Oct 2025 · 0 likes Taking post #35 at face value and following it one step further. Weight reduction figures from SURMOUNT-1 are frequently quoted without the trial's duration attached. A…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #96 · Evidence › Study critique · 15 Sep 2025 · 29 likes The most useful thing anyone has posted about Reverse causation in this category was a table of what had been measured and by whom. That is what I would want again.
Confounding by indication, explained with a concrete example Replied, post #21 · Evidence › Study critique · 2 Sep 2025 · 0 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #120 · Compounds › Secretagogues & GH axis · 1 Sep 2025 · 26 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Hepatic impairment and the absence of data Replied, post #21 · Clinical › Special populations · 27 Aug 2025 · 22 likes Post #19 describes the usual case. This is about the unusual one. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed…
Criticising the method without criticising the authors — one year on Replied, post #18 · Evidence › Study critique · 19 Aug 2025 · 5 likes Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking. I would be interested in a…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #88 · Clinical › Comorbidities · 8 Aug 2025 · 12 likes On Cardiovascular risk: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
Substitution between formats during a shortage Replied, post #34 · Access › Shortages · 6 Aug 2025 · 1 like Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
A ten-fold dose error caught before injection — one year on Replied, post #108 · Devices › Syringes & needles · 4 Aug 2025 · 12 likes Confirming post #106 from a second method, which matters more than confirming it from a second person. Drawing through a wider needle and injecting through a thinner…
Managing an unplanned gap in supply — what changed since Replied, post #25 · Access › Shortages · 27 Jul 2025 · 0 likes This follows post #24 rather than contradicting it. I would put moderate confidence on the mainstream reading of Managing an unplanned gap and no more. That is not…
Antibiotics and a course of something with delayed emptying Replied, post #101 · Practice › Interactions · 26 Jul 2025 · 29 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Specification in the result column: why that is a meaningful error Replied, post #18 · Analytics › COA interpretation · 13 Jul 2025 · 0 likes Picking up post #16: that is the part I would want checked first. The distinction between release testing and characterisation is one industrial documents make and…
Micronutrient status when intake falls substantially Replied, post #15 · Clinical › Bloodwork · 5 Jul 2025 · 4 likes Where I part company with post #11, and it is a narrow parting. The bit of micronutrient status that nobody enjoys is that the answer changes depending on what you are…
Repeatability versus intermediate precision Replied, post #90 · Analytics › Method validation · 29 Jun 2025 · 7 likes Repeatability versus intermediate precision was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #13 · Analytics › COA interpretation · 14 Jun 2025 · 7 likes Reading back through, this was answered upthread and I missed it. My fault.
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #20 · Compounds › Semaglutide · 8 Jun 2025 · 3 likes Worth separating two things this subcategory keeps merging: what the molecule does, which is reasonably well characterised, and what a particular vial contains, which…
Coming back to: Getting a referral rather than a refusal Replied, post #14 · Clinical › Prescriber conversations · 30 May 2025 · 13 likes Adding a small correction to the Getting a referral summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that…
Pre-registering a personal experiment, seriously Replied, post #10 · Research Methods › N-of-1 designs · 26 May 2025 · 24 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve. I keep a log…
Reporting a disappointing outcome, and why it belongs here Replied, post #14 · Outcomes › Progress reports · 21 May 2025 · 31 likes That matches what I have seen, for whatever a single anecdote is worth.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #38 · Sourcing › Independent verification · 13 May 2025 · 25 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #67 · Evidence › Journal club · 2 Apr 2025 · 14 likes Post #63 describes the usual case. This is about the unusual one. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
Cost per milligram, computed honestly across formats — the long version Replied, post #50 · Access › Pricing · 31 Mar 2025 · 1 like Compute cost per delivered dose at your dose if you want a number you can act on. That requires knowing your dose, vial volume, and whether you are using a vial or a pen.
Biased agonism: a real phenomenon, an over-used explanation Replied, post #94 · Pharmacology › Receptor biology · 14 Mar 2025 · 0 likes Post #92 is right about the mechanism and I think understates the practical bit. I have been on both sides of the biased agonism argument in this category within…
A promotion I argued against, and why I lost Replied, post #126 · Documentation › Doc review · 9 Mar 2025 · 0 likes A promotion that is declined should leave the topic linked from wherever the question recurs, so the work is not lost. That holds for the case as described. Change the…
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #13 · Start Here › Welcome · 5 Mar 2025 · 5 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
What we do not know about retatrutide, listed explicitly Replied, post #106 · Compounds › Retatrutide · 21 Feb 2025 · 0 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
Journal club: SURMOUNT-1, read without the press release Replied, post #56 · Evidence › Journal club · 6 Feb 2025 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
Protein density versus volume when you cannot eat much Replied, post #70 · Nutrition & Training › Protein & intake · 4 Feb 2025 · 2 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
Pancreatitis history and the risk calculus — a second dataset Replied, post #22 · Safety › Contraindications · 2 Feb 2025 · 0 likes Adding the measurement that post #21 says would settle it. Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #49 · Analytics › COA interpretation · 24 Jan 2025 · 3 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #127 · Compounds › Tirzepatide · 3 Jan 2025 · 23 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
People with a low starting BMI: where the evidence stops Replied, post #26 · Clinical › Special populations · 23 Dec 2024 · 0 likes Coming back to post #24, because the follow-up matters more than the original answer. Dedicated trials in under-studied populations are the only real remedy and several…
When "no data" is the complete and final answer Replied, post #46 · Compounds › Other compounds · 20 Dec 2024 · 0 likes On analysis: unusual or modified sequences are exactly where a default reversed-phase method is least likely to be appropriate. A supplier that runs everything on one…
Time to steady state after a dose increase Replied, post #117 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 15 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #42 · Clinical › Comorbidities · 16 Oct 2024 · 16 likes Post #38 and I disagree about the size of the effect, not about the direction. A definition problem is doing most of the work in this Hypertension improvement…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #65 · Access › Shortages · 11 Oct 2024 · 8 likes On post #61 — agreed on the reasoning, with one qualification. International supply chains: a shortage in one country does not mean shortage in another. That is why…
Guidelines revision: what changed and why Replied, post #137 · Meta › Announcements · 29 Jul 2024 · 1 like Reading the changed pages: the diff is smaller than the announcement implies, which is reassuring rather than disappointing. A large change to a documentation page…
Journal club: FLOW and the renal composite, component by component Replied, post #7 · Evidence › Journal club · 8 Jul 2024 · 5 likes The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to. The…
The mass-error checker and its intended scope Replied, post #90 · Data & Tools › Calculators · 1 Jul 2024 · 18 likes One caution on mass-error checker: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #5 · Nutrition & Training › Resistance training · 5 Jun 2024 · 7 likes Second this, and I would have said it less carefully.